Developing new, innovative models in delivering health care are needed to support the growing population of older adults in Canada, say researchers from the Geras Centre for Aging Research.
The medication, known as mifepristone/misoprostol, was approved for use by Health Canada in 2017 and is listed by the World Health Organization as an essential medication.
The study tackles contradictory research findings related to the effectiveness of ketone supplements, which have gained popularity among athletes seeking a competitive advantage.